Armitage: “I am doing what I can” to keep Kappos at USPTO

Managing IP is part of Legal Benchmarking Limited, 1-2 Paris Gardens, London, SE1 8ND

Copyright © Legal Benchmarking Limited and its affiliated companies 2025

Accessibility | Terms of Use | Privacy Policy | Modern Slavery Statement

Armitage: “I am doing what I can” to keep Kappos at USPTO

armitage-45.jpg

Following an announcement that he will retire as Eli Lilly’s senior vice president and general counsel at the end of this year, Robert Armitage would not indicate whether he is interested in taking over as USPTO director, instead saying he is urging Kappos to stay on

armitage.jpg

Armitage has been a leading figure in patent law for over 30 years, and was actively involved in the creation and enactment of the AIA. He will be replaced by Michael Harrington, who has been promoted from vice president and deputy general counsel, global pharmaceutical operations at Eli Lilly, effective January 1 2013.

Although Armitage said he has not decided on next steps following his retirement, he is on the IP community’s list of potential Democratic party candidates to replace David Kappos as USPTO director. While Kappos may choose to stay on if President Barack Obama is re-elected, Managing IP sources have indicated he may want to leave.

When asked if he would consider the USPTO position, Armitage described Kappos as “a uniquely talented and able director”. He added: “I am doing what I can to urge him to continue in the role, to see many of the transformational changes in the USPTO to a successful conclusion.”



more from across site and SHARED ros bottom lb

More from across our site

The tie-up could result in the firm’s German and France-based teams, which both have strong UPC expertise, becoming independent
News of a slowdown in the UK’s clean energy IP landscape and an EPO report on unitary patent uptake were also among the top talking points
Price hikes at ‘big law’ firms are pushing some clients toward boutiques that offer predictable fees, specialised expertise, and a model built around prioritising IP
The Australian side, in particular, can benefit by capitalising on its independent status to bring in more work from Western countries while still working with its former Chinese partner
Koen Bijvank of Brinkhof and Johannes Heselberger of Bardehle Pagenberg discuss the Amgen v Sanofi case and why it will be cited frequently
View the official winners of the 2025 Social Impact EMEA Awards
King & Wood Mallesons will break into two entities, 14 years after a merger between a Chinese and an Australian firm created the combined outfit
Teams from Shakespeare Martineau and DWF will take centre stage in a dispute concerning the registrability of dairy terminology in plant-based products
Senem Kayahan, attorney and founder at PatentSe, discusses how she divides prosecution tasks, and reveals the importance of empathetic client advice
The association’s Australian group has filed a formal complaint against the choice of venue, citing Dubai as an unsafe environment for the LGBTQIA+ community
Gift this article